These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 16087656)
1. Disc methods for detecting AmpC {beta}-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae. Brenwald NP; Jevons G; Andrews J; Ang L; Fraise AP J Antimicrob Chemother; 2005 Sep; 56(3):600-1. PubMed ID: 16087656 [No Abstract] [Full Text] [Related]
2. Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis. Tan TY; Ng SY; Teo L; Koh Y; Teok CH J Clin Pathol; 2008 May; 61(5):642-4. PubMed ID: 18057079 [TBL] [Abstract][Full Text] [Related]
3. Detection of extended-spectrum beta-lactamases by using boronic acid as an AmpC beta-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli. Song W; Bae IK; Lee YN; Lee CH; Lee SH; Jeong SH J Clin Microbiol; 2007 Apr; 45(4):1180-4. PubMed ID: 17301276 [TBL] [Abstract][Full Text] [Related]
4. [Identification of a plasmid-mediated AmpC beta-lactamase from clinical isolates of Escherichia coli and Klebsiella pneumoniae]. Wang Y; Li ZH Zhonghua Jie He He Hu Xi Za Zhi; 2005 Oct; 28(10):685-8. PubMed ID: 16255953 [TBL] [Abstract][Full Text] [Related]
5. [Detection of plasmid-mediated AmpC beta-lactamase in clinical isolates of cefoxitin-resistant Escherichia coli and Klebsiella pneumoniae]. Coşkun S; Altanlar N Mikrobiyol Bul; 2012 Jul; 46(3):375-85. PubMed ID: 22951650 [TBL] [Abstract][Full Text] [Related]
6. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance. Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482 [TBL] [Abstract][Full Text] [Related]
7. Activity of mecillinam against AmpC beta-lactamase-producing Escherichia coli. Brenwald NP; Andrews J; Fraise AP J Antimicrob Chemother; 2006 Jul; 58(1):223-4. PubMed ID: 16698846 [No Abstract] [Full Text] [Related]
8. Identification of extended-spectrum, AmpC, and carbapenem- hydrolyzing beta-lactamases in Escherichia coli and Klebsiella pneumoniae by disk tests. Jacoby GA; Walsh KE; Walker VJ J Clin Microbiol; 2006 Jun; 44(6):1971-6. PubMed ID: 16757586 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of phenotypic screening methods for detecting plasmid-mediated AmpC beta-lactamases-producing isolates of Escherichia coli and Klebsiella pneumoniae. Lee K; Hong SG; Park YJ; Lee HS; Song W; Jeong J; Yong D; Chong Y Diagn Microbiol Infect Dis; 2005 Dec; 53(4):319-23. PubMed ID: 16269222 [TBL] [Abstract][Full Text] [Related]
10. Inhibitor-based methods for detection of plasmid-mediated AmpC beta-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis. Coudron PE J Clin Microbiol; 2005 Aug; 43(8):4163-7. PubMed ID: 16081966 [TBL] [Abstract][Full Text] [Related]
11. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase. Weston GS; Blázquez J; Baquero F; Shoichet BK J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697 [TBL] [Abstract][Full Text] [Related]
12. Detection and reporting beta-lactam resistance phenotypes in Escherichia coli and Klebsiella pneumoniae: a multicenter proficiency study in Spain. Conejo MC; Mata C; Navarro F; Pascual A; Diagn Microbiol Infect Dis; 2008 Nov; 62(3):317-25. PubMed ID: 18692340 [TBL] [Abstract][Full Text] [Related]
13. New method for laboratory detection of AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniae. Nasim K; Elsayed S; Pitout JD; Conly J; Church DL; Gregson DB J Clin Microbiol; 2004 Oct; 42(10):4799-802. PubMed ID: 15472344 [TBL] [Abstract][Full Text] [Related]
14. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli. Duttaroy B; Mehta S Indian J Pathol Microbiol; 2005 Jan; 48(1):45-8. PubMed ID: 16758790 [TBL] [Abstract][Full Text] [Related]
15. [Research regarding extended-spectrum beta-lactamases produced by enterobacteria strains]. Copăcianu B; Tuchiluş C; Poiata A; Iancu LS Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):896-9. PubMed ID: 21243821 [TBL] [Abstract][Full Text] [Related]
16. Phenotypic detection of extended-spectrum and AmpC beta-lactamases by a new spot-inoculation method and modified three-dimensional extract test: comparison with the conventional three-dimensional extract test. Shahid M; Malik A; Agrawal M; Singhal S J Antimicrob Chemother; 2004 Sep; 54(3):684-7. PubMed ID: 15294886 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of a double synergy differential test (DSDT) for differential detection of ESBL and AmpC-type β-lactamases in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis. Sabia C; Gargiulo R; Sarti M New Microbiol; 2012 Apr; 35(2):221-5. PubMed ID: 22707136 [TBL] [Abstract][Full Text] [Related]
18. Association of QnrB determinants and production of extended-spectrum beta-lactamases or plasmid-mediated AmpC beta-lactamases in clinical isolates of Klebsiella pneumoniae. Pai H; Seo MR; Choi TY Antimicrob Agents Chemother; 2007 Jan; 51(1):366-8. PubMed ID: 17074790 [TBL] [Abstract][Full Text] [Related]
19. Occurrence and detection of AmpC beta lactamases among clinical isolates of E. coli and K. pneumoniae causing UTI. Rajni E; Rawat U; Malhotra VL; Mehta G J Commun Dis; 2008 Mar; 40(1):21-5. PubMed ID: 19127665 [TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activity of ertapenem against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated in Spain. Hernández JR; Velasco C; Romero L; Martínez-Martínez L; Pascual A Int J Antimicrob Agents; 2006 Nov; 28(5):457-9. PubMed ID: 17008066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]